Creative Planning’s Mustang Bio MBIO Stock Holding History

Creative Planning’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28	Closed	-$7.7K	–	2750
2023 Q1	$7.7K	Buy	28 +1	+4%	+$410	﹤0.01%	2475
2022 Q4	$7.9K	Hold	27	–	–	﹤0.01%	2371
2022 Q3	$9K	Buy	+27	New	+$12.5K	﹤0.01%	2239
2021 Q2	–	Sell	-13	Closed	-$34K	–	2374
2021 Q1	$34K	Sell	13 -2	-13%	-$5.95K	﹤0.01%	2397
2020 Q4	$44K	Buy	+15	New	+$35.9K	﹤0.01%	2117

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Creative Planning's MBIO Position: Q2 2023 in Review

Creative Planning sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 28 shares — an estimated $7.7K sold.

Creative Planning first reported a position in MBIO in Q4 2020 and held it in 5 quarters. The position peaked at $44K in Q4 2020. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Creative Planning reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Creative Planning sold 28 Mustang Bio shares in Q2 2023, an estimated $7.7K.
Creative Planning first reported a position in Mustang Bio in Q4 2020 and held it in 5 quarters.
Creative Planning's Mustang Bio position peaked at $44K in Q4 2020.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Creative Planning's 13F filing for Q2 2023, filed 21 Jul 2023.